메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류
인문학
인문학 일반 역사학 철학 종교학 어문학 기타 인문학
사회과학
사회과학 일반 경영학 관광학 교육학 군사학 문헌정보학 법학 사회학 신문방송학 심리과학 정치외교학 지리학 행정학 경제학 무역학 인류학 기타 사회과학
자연과학
자연과학 일반 물리학 생물학 생활과학 수학·통계학 천문학 지구과학 화학 기타 자연과학
공학
공학 일반 건축공학 기계공학 산업공학 재료·에너지공학 전기전자공학 조선해양공학 화학공학 컴퓨터학 기타공학
의약학
의학 일반 간호학 수의학 약학 한의학 기초의학 임상의학 기타 의약학
농수해양학
농수해양학 일반 농학 수산학 식품과학 임학 축산학 해상운송학 기타 농수해양학
예술체육학
예술 일반 디자인 미술 미용 사진 음악학 의상 체육 공연매체예술 기타 예술체육학
복합학
학제간연구 과학기술학 뇌인지과학 기술정책 기타 복합학

ENG

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한뇌졸중학회 대한뇌졸중학회지 대한뇌졸중학회지 제19권 제3호
발행연도
2017.1
수록면
347 - 355 (9page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background and Purpose Standard operating procedures (SOP) incorporating plasma levels of rivaroxaban might be helpful in selecting patients with acute ischemic stroke taking rivaroxaban suitable for IVthrombolysis(IVT) or endovascular treatment (EVT). Methods This was a single-center explorative analysis using data from the Novel-Oral-Anticoagulants-in-Stroke-Patients-registry (clinicaltrials.gov:NCT02353585) including acute stroke patients taking rivaroxaban(September 2012 to November 2016). The SOP included recommendation, consideration, and avoidance of IVT if rivaroxaban plasma levels were <20 ng/mL, 20‒100 ng/mL, and >100 ng/mL, respectively, measured with a calibrated anti-factor Xa assay. Patients with intracranial artery occlusion were recommended IVT+EVT or EVT alone if plasma levels were ≤100 ng/mL or >100 ng/mL, respectively. We evaluated the frequency of IVT/EVT, door-to-needle-time (DNT), and symptomatic intracranial or major extracranial hemorrhage. Results Among 114 acute stroke patients taking rivaroxaban, 68 were otherwise eligible for IVT/EVT of whom 63 had plasma levels measured (median age 81 years, median baseline National Institutes of Health Stroke Scale 6). Median rivaroxaban plasma level was 96 ng/mL (inter quartile range [IQR] 18‒259 ng/mL) and time since last intake 11 hours (IQR 4.5‒18.5 hours). Twenty-two patients (35%) received IVT/EVT (IVT n=15, IVT+EVT n=3, EVT n=4) based on SOP. Median DNT was 37 (IQR 30‒60) minutes. None of the 31 patients with plasma levels >100ng/mL received IVT. Among 14 patients with plasma levels ≤100 ng/mL, the main reason to withhold IVT was minor stroke (n=10). No symptomatic intracranial or major extracranial bleeding occurred after treatment. Conclusions Determination of rivaroxaban plasma levels enabled IVT or EVT in one-third of patients taking rivaroxaban who would otherwise be ineligible for acute treatment. The absence of major bleeding in our pilot series justifies future studies of this approach.
#Rivaroxaban #Stroke #Plasma levels #Thrombolysis

목차

등록된 정보가 없습니다.

참고문헌 (1)

참고문헌 신청
Hacke W / 2008 / Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke / N Engl J Med 359 : 1317 ~ 1329 | 2. [학술지(정기간행물)] - Hacke W / 1998 / Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators / Lancet 352 : 1245 ~ 1251 | 3. [학술지(정기간행물)] - IST-3 collaborative group / 2012 / The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial / Lancet 379 : 2352 ~ 2363 | 4. [학술지(정기간행물)] - Wahlgren N / 2007 / Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study / Lancet 369 : 275 ~ 282 | 5. [학술지(정기간행물)] - Patel MR / 2011 / Rivaroxaban versus warfarin in nonvalvular atrial fibrillation / N Engl J Med 365 : 883 ~ 891 | 6. [학술지(정기간행물)] - Hankey GJ / 2014 / Management of acute stroke in patients taking novel oral anticoagulants / Int J Stroke 9 : 627 ~ 632 | 7. [학술지(정기간행물)] - Mazya MV / 2013 / Safety of intravenous thrombolysis for ischemic stroke in patients treated with warfarin / Ann Neurol 74 : 266 ~ 274 | 8. [학술지(정기간행물)] - Xian Y / 2012 / Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator / JAMA 307 : 2600 ~ 2608 | 9. [학술지(정기간행물)] - Nogueira RG / 2009 / Safety and efficacy of endovascular thrombectomy in patients with abnormal hemostasis: pooled analysis of the MERCI and multi MERCI trials / Stroke 40 : 516 ~ 522 | 10. [학술지(정기간행물)] - De Marchis GM / 2011 / Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants / Stroke 42 : 3061 ~ 3066 | 11. [학술지(정기간행물)] - Harenberg J / 2012 / Measurement of the new anticoagulants / Thromb Res 129 (Suppl 1) : S106 ~ S113 | 12. [학술지(정기간행물)] - Purrucker JC / 2017 / Coagulation testing in acute ischemic stroke patients taking non-vitamin K antagonist oral anticoagulants / Stroke 48 : 152 ~ 158 | 13. [학술지(정기간행물)] - Cuker A / 2014 / Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants / J Am Coll Cardiol 64 : 1128 ~ 1139 | 14. [학술지(정기간행물)] - Seiffge DJ / 2017 / Feasibility of rapid measurement of rivaroxaban plasma levels in patients with acute stroke / J Thromb Thrombolysis 43 : 112 ~ 116 | 15. [학술지(정기간행물)] - Seiffge DJ / 2014 / Intravenous thrombolysis in stroke patients receiving rivaroxaban / Eur J Neurol 21 : e3 ~ e4 | 16. [학술지(정기간행물)] - Ringelstein EB / 2013 / European Stroke Organisation recommendations to establish a stroke unit and stroke center / Stroke 44 : 828 ~ 840 | 17. [학술지(정기간행물)] - Seiffge DJ / 2015 / Recanalization therapies in acute ischemic stroke patients:impact of prior treatment with novel oral anticoagulants on bleeding complications and outcome / Circulation 132 : 1261 ~ 1269 | 18. [학술지(정기간행물)] - Demaerschalk BM / 2016 / Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association / Stroke 47 : 581 ~ 641 | 19. [학술지(정기간행물)] - Jauch EC / 2013 / Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association / Stroke 44 : 870 ~ 947 | 20. [학술지(정기간행물)] - Lyden P / 1994 / Improved reliability of the NIH stroke scale using video training. NINDS TPA Stroke Study Group / Stroke 25 : 2220 ~ 2226 | 21. [학술지(정기간행물)] - Levey AS / 2009 / A new equation to estimate glomerular filtration rate / Ann Intern Med 150 : 604 ~ 612 | 22. [학술지(정기간행물)] - Gensicke H / 2013 / IV thrombolysis and renal function / Neurology 81 : 1780 ~ 1788 | 23. [학술지(정기간행물)] - Gensicke H / 2013 / Long-term outcome in stroke patients treated with IV thrombolysis / Neurology 80 : 919 ~ 925 | 24. [학술지(정기간행물)] - Scheitz JF / 2014 / Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke / Stroke 45 : 509 ~ 514 | 25. [학술지(정기간행물)] - Hacke W / 1995 / Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) / JAMA 274 : 1017 ~ 1025 | 26. [학술지(정기간행물)] - National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group / 1995 / Tissue plasminogen activator for acute ischemic stroke / N Engl J Med 333 : 1581 ~ 1587 | 27. [학술지(정기간행물)] - Dennis M / 2012 / Determining the modified rankin score after stroke by postal and telephone questionnaires / Stroke 43 : 851 ~ 853 | 28. [학술지(정기간행물)] - Powers WJ / 2015 / 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association / Stroke 46 : 3020 ~ 3035 | 29. [학술지(정기간행물)] - Mueck W / 2011 / Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention / Clin Pharmacokinet 50 : 675 ~ 686 | 30. [학술지(정기간행물)] - Steiner T / 2013 / Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban / Clin Res Cardiol 102 : 399 ~ 412 | 31. [학술지(정기간행물)] - Barber PA / 2000 / Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta stroke programme early CT score / Lancet 355 : 1670 ~ 1674 | 32. [학술지(정기간행물)] - Mueck W / 2008 / Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement / Thromb Haemost 100 : 453 ~ 461 | 33. [학술지(정기간행물)] - Meretoja A / 2010 / Off-label thrombolysis is not associated with poor outcome in patients with stroke / Stroke 41 : 1450 ~ 1458 | 34. [학술지(정기간행물)] - Kepplinger J / 2016 / Standardized use of novel oral anticoagulants plasma level thresholds in a new thrombolysis decision making protocol / J Thromb Thrombolysis 41 : 293 ~ 300 | 35. [학술지(정기간행물)] - Xian Y / 2017 / Use of intravenous recombinant tissue plasminogen activator in patients with acute ischemic stroke who take non-vitamin K antagonist oral anticoagulants before stroke / Circulation 135 : 1024 ~ 1035 | 36. [학술지(정기간행물)] - Ebner M / 2015 / Point-of-care testing of coagulation in patients treated with non-vitamin K antagonist oral anticoagulants / Stroke 46 : 2741 ~ 2747 google schola

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0